Maravai LifeSciences Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, focuses on providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Maravai LifeSciences Holdings serves customers worldwide.

Current Report (Form 8-K | Period ending 2024-12-18)

Current Report (Form 8-K | Period ending 2024-12-03)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Maravai LifeSciences Holdings (MRVI US)

Current Report (Form 8-K | Period ending 2024-12-18)

Current Report (Form 8-K | Period ending 2024-12-03)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-07)

Current Report (Form 8-K | Period ending 2024-09-10)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)